Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AEON Biopharma Inc
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
May 20, 2026
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
May 19, 2026
AEON Biopharma Appoints John Bencich as Chief Financial Officer
May 18, 2026
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
January 21, 2026